Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients Véronique QuillienAntoine F. CarpentierElodie Vauleon Original Article Open access 04 March 2019 Pages: 871 - 882
HCT-116 colorectal cancer cells secrete chemokines which induce chemoattraction and intracellular calcium mobilization in NK92 cells Noha Mousaad ElemamZaidoon Al-JaderiAzzam A. Maghazachi Original Article 07 March 2019 Pages: 883 - 895
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition Vylyny ChatRobert FergusonTomas Kirchhoff Original Article 12 March 2019 Pages: 897 - 905
DNA lesions correlate with lymphocyte function after selective internal radiotherapy Aglaia DomouchtsidouVahé BarsegianMonika Lindemann Original Article 15 March 2019 Pages: 907 - 915
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer Kenneth L. KehlShihao YangDeborah Schrag Original Article 15 March 2019 Pages: 917 - 926
An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma Panagiotis TsagozisMartin AugstenMonika Ehnman Original Article Open access 16 March 2019 Pages: 927 - 936
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma Kim C. M. SantegoetsPaul R. GielenGosse J. Adema Original Article Open access 05 April 2019 Pages: 937 - 949
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas Lucie DuvergerAmélie OsioMaxime Battistella Original Article 05 April 2019 Pages: 951 - 960
Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model Ming ChenMin XuFeng Zhou Original Article 06 April 2019 Pages: 961 - 971
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy Sebastian KleinCornelia MauchDoris Helbig Original Article 08 April 2019 Pages: 973 - 982
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series Selma UgurelIvelina SpassovaJürgen C. Becker Original Article 16 April 2019 Pages: 983 - 990
Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy Bradley C. HollandAkshay SoodShaheen Alanee Original Article 17 April 2019 Pages: 991 - 997
Systemic and local immunosuppression in patients with high-grade meningiomas Yuping D. LiDorina VeliceasaOrin Bloch Original Article 27 April 2019 Pages: 999 - 1009
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile Daniëlle KrijgsmanNatasja L. de VriesPeter J. K. Kuppen Original Article Open access 03 May 2019 Pages: 1011 - 1024
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial Bas D. KosterSaskia J. A. M. SantegoetsAlfons J. M. van den Eertwegh Clinical Trial Report Open access 09 March 2019 Pages: 1025 - 1035
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial Bas D. KosterSaskia J. A. M. SantegoetsAlfons J. M. van den Eertwegh Correction 27 March 2019 Pages: 1037 - 1037
